RxDoctor Payments DataLook up a doctor →

Michael Cross, MD

Orthopaedic Surgery · Indianapolis, INNPI 1235397043

Payments from drug & device makers

$1,014,102in general payments, 2019–2025

Across 494 payments — averaging $2052.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$294K
  • Medical Device Business Services, Inc.$205K
  • KCI USA, Inc.$132K
  • Intellijoint Surgical Inc.$125K
  • Encore Medical, LP$90K
  • Smith+Nephew$58K
  • plus $111K from 13 others
$2,500in research payments, 2019–2025

Across 1 payment — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exactech, Inc.$3K

What the payments were for

  • Royalty or licence$211,46824%
  • Consulting fees$397,12446%
  • Speaking & faculty fees$101,33812%
  • Travel & lodging$59,6917%
  • Food & beverage$10,1891%
  • Education$5500%
  • Gifts$1140%
  • Other$89,78210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,014,102 in reported general payments places this provider in the 95th percentile of 400 orthopaedic surgery providers in Indiana.

See all orthopaedic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$176,922
Medicare patients
344
Services billed
10,928

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$31,871
Diclofenac Sodium271$2,719
Oxycodone Hcl322$1,979
Cefadroxil162$1,794
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$374
Celecoxib29$318
Doxycycline Hyclate19$208
Meloxicam48$198
Tramadol Hcl51$177
Ondansetron OdtOndansetron12$139
Gabapentin18$127
Amoxicillin54$111
Cephalexin35$54
Clindamycin Hcl13$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →